Back to All Events

MASTERMIND: Lisa Deschamps (AviadoBio) & Joe Sandys (Cooley LLP): AviadoBio’s $2.18 Billion Gene Therapy Agreement with Astellas

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. 

Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise. 

Previous
Previous
March 4

INSIGHTS/ The CEO: Jonathan Montagu, Co-Founder and CEO of HotSpot Therapeutics – Do Transatlantic Ventures have a USP?

Next
Next
April 1

INSIGHTS/ The Expert: Jeff Berkowitz (Real Endpoints) - U.S. Market Access and Reimbursement Strategies for CEOs